<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Guidance for Clinical Investigators, Sponsors, and Institutional Review Boards on Investigational New Drug Applications-Determining Whether Human Research Studies Can Be Conducted Without an Investigational New Drug Application; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Guidance for Clinical Investigators, Sponsors, and Institutional Review Boards on Investigational New Drug Applications-Determining Whether Human Research Studies Can Be Conducted Without an Investigational New Drug Application; Availability</h1>
    <p class="timestamp">Published: 2013-09-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a guidance for clinical investigators, sponsors, and institutional review boards (IRBs) entitled "Investigational New Drug Applications (INDs)--Determining Whether Human Research Studies Can Be Conducted Without an IND." The guidance is intended to assist clinical investigators, sponsors, sponsor-investigators, and IRBs in determining whether human research studies must be conducted under an IND. The guidance describes the ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-21889</p>
    <p><strong>Publication Date:</strong> 2013-09-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/09/10/2013-21889/guidance-for-clinical-investigators-sponsors-and-institutional-review-boards-on-investigational-new">https://www.federalregister.gov/documents/2013/09/10/2013-21889/guidance-for-clinical-investigators-sponsors-and-institutional-review-boards-on-investigational-new</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-21889</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
